---
title: CMC Pharmaceuticals, Inc. vs Onyx Scientific
slug_a: cmcpharm
slug_b: onyxipca
site: cdmo
review_signal_gate: closed
canonical_path: /compare/cmcpharm/onyxipca
generated_by: BioBM Editorial AI
---

# CMC Pharmaceuticals, Inc. vs Onyx Scientific

This comparison is auto-generated by BioBM Editorial AI and intended as an evidence-oriented side-by-side reference.

## Company A

CMC Pharmaceuticals, Inc. (cmcpharm) is listed for cdmo. CMC Pharma provides integrated formulation development, analytical testing, stability studies, and cGMP manufacturing oversight for small molecule drug programs from preclinical through post-approval, with hands-on regulatory expertise and CMO management built in.

Services: 11. Modalities: 1. Indications: 0. Locations: 1. Certifications: 0. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (11).

Review summary: Review summary withheld until site-level review gate opens.

## Company B

Onyx Scientific (onyxipca) is listed for cdmo. Small molecule CDMO specialising in process chemistry, solid-state chemistry, and API manufacturing for Phase I–III and commercial supply. Licensed for commercial API production at its Sunderland, UK facility, with a second site in North Carolina, US.

Services: 7. Modalities: 1. Indications: 0. Locations: 2. Certifications: 0. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (7).

Review summary: Review summary withheld until site-level review gate opens.